The Affordable Care Act (ACA) will have a significant impact on addiction treatment in the U.S. More insurance plans will cover the cost of treatment, but only those that are evidence-based. ACA will also encourage greater coordination between primary care, mental health and addiction services.
CBAM is at the forefront of this change, having spearheaded the establishment of behavioral and addiction medicine clinics within a primary care setting at UCLA. With those clinics currently operating at sustainable levels, we have begun to share our knowledge with others through publications in medical journals and partnerships with government and nonprofit organizations to teach evidence-based practices in community clinics. CBAM also conducts research to advance the treatment of addictions and to create more evidence-based approaches for clinicians to use in their practices.